Sentinel Oncology

Sentinel Oncology is a biotechnology company developing targeted small-molecule drugs for difficult-to-treat cancers.

Its medicinal chemistry programmes investigate DNA damage responses and cell division. Some candidates are designed to cross the blood-brain barrier, targeting primary brain tumours and cancers that spread to the brain.

The company also investigates treatments for rare neurological conditions and works with pharmaceutical partners to advance selected candidates through licensing and clinical development.